- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
688293
SHH
Week ended 07 Aug 2026
Weekly Investor Report
Shanghai OPM Biosciences Co., Ltd. · Healthcare · Biotechnology
Latest close
63.22 CNY
28.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 29.8% above the Trend Line and sits at 86.2% of its 52-week range. The latest completed week returned 28.0%, after a 30.6% four-week move. The latest news-sentiment score is 50/100.
Setup score
62
out of 100
Latest Close
63.22 CNY
7 Aug 2026
1W Return
28.0%
latest completed week
4W Return
30.6%
short-term follow-through
12W Return
37.0%
quarterly tape
Trend Breadth
38.5%
20 of 52 weeks active
Volume Ratio
2.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 44.54% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 1 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
28.0%
Latest completed week; four-week move 30.6%.
Indicator stack
21/97
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.54%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 29.8% above the Trend Line and sits at 86.2% of its 52-week range. The latest completed week returned 28.0%, after a 30.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.1x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1612-week average 0.10
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 30.6% over four weeks, 37.0% over 12 weeks, and 4.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year20
Trend breadth38.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.22Latest activity-pressure read.
Pressure change313.4%Four-week change in activity pressure.
Leadership22.86Latest relative-leadership reading.
RS change380.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-6.8%Distance below the 52-week high.
13-week volatility11.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+28.0%Week of 7 Aug.
Worst week-14.5%Week of 5 Jun.
Latest week+28.0%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains4
Flat weeks0
Modest losses6
Sharp losses8
Recent vol11.3%13-week weekly-return volatility.
Base vol8.7%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew8.3% / -5.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank- / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Biotechnology
4-week rank5 / 100
Group average4.5%
Trend breadth15.0%
Trend15.0%active weekly trend signals
MD37.0%positive activity pressure
RS32.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis19/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 3/12.
Activity pressure 0.16; 1 reversal markers Next-Week ExpectancyNegative 44.54%Next-week expectancy is negative with a 44.54% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 63.22 CNY | 28.0% | 48.69 CNY | 44.41 CNY | 1.22 | 22.86 | 23.7M | Off |
| 31 Jul 2026 | 49.40 CNY | -6.6% | 48.22 CNY | 44.28 CNY | 0.98 | -1.45 | 16.9M | Off |
| 24 Jul 2026 | 52.87 CNY | 2.0% | 48.32 CNY | 44.25 CNY | 0.58 | 5.58 | 28.4M | Off |
| 17 Jul 2026 | 51.82 CNY | 7.1% | 48.31 CNY | 44.20 CNY | -0.03 | 4.62 | 29.1M | Off |
| 10 Jul 2026 | 48.39 CNY | 9.7% | 48.36 CNY | 44.16 CNY | -0.57 | -8.14 | 14.8M | Off |
| 3 Jul 2026 | 44.11 CNY | 17.7% | 48.44 CNY | 44.13 CNY | -1.12 | -17.32 | 1.8M | Off |
| 26 Jun 2026 | 37.48 CNY | -1.2% | 48.85 CNY | 44.14 CNY | -1.36 | -29.54 | 2.6M | Off |
| 19 Jun 2026 | 37.91 CNY | 6.5% | 49.43 CNY | 44.20 CNY | -1.33 | -30.02 | 6.1M | Off |
| 12 Jun 2026 | 35.61 CNY | -4.5% | 50.12 CNY | 44.30 CNY | -1.26 | -33.51 | 1.6M | Off |
| 5 Jun 2026 | 37.28 CNY | -14.5% | 50.80 CNY | 44.41 CNY | -0.89 | -30.67 | 1.8M | Off |
| 29 May 2026 | 43.61 CNY | -4.5% | 51.62 CNY | 44.52 CNY | -0.55 | -20.11 | 4.1M | Off |
| 22 May 2026 | 45.65 CNY | -1.0% | 52.05 CNY | 44.59 CNY | -0.38 | -17.45 | 6.4M | Off |
| 15 May 2026 | 46.13 CNY | -11.1% | 52.37 CNY | 44.66 CNY | -0.18 | -17.15 | 9.8M | Off |
| 8 May 2026 | 51.88 CNY | 3.3% | 52.86 CNY | 44.74 CNY | -0.02 | -7.99 | 4.4M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.